Chloroquine attenuates TLR3/IFN-β signaling in cultured normal human mesangial cells: A possible protective effect against renal damage in lupus nephritis

References

• Ben-Zvi I, Kivity S, Langevivts P, Shoenfeld Y. Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol. 2012;42:145–53.
   PubMed Web of Science ®Google Scholar
• Tang C, Godfrey T, Stawell R, Nikpour M. Hydroxychloroquine in lupus: emerging evidence supporting multiple beneficial effects. Intern Med J. 2012;42:968–78.
   PubMed Web of Science ®Google Scholar
• Pons-Estel G, Alarcon GA, McGwin G, Danila MI, Zhang J, Bastian HM, et al. Protective effect of hydroxychloroquine in renal damage in patients with lupus nephritis: LXV, data from a multiethnic US cohort. Arthritis Rheum. 2009;61:830–9.
   PubMed Web of Science ®Google Scholar
• Bertsias G, Tektonidou M, Amoura Z, Aringer M, Bajema I, Berden JH, et al. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adults and paediatric lupus nephritis. Ann Rheum Dis. 2012;71:1771–82.
   PubMed Web of Science ®Google Scholar
• Hagberg N, Rönnblom L. Systemic lupus erythematosus-A disease with a dysregulated type I interferon system. Scand J Immunol. 2015;82:199–207.
   PubMed Web of Science ®Google Scholar
• Anders HS. Pseudoviral immunity – a novel concept for lupus. Trends Mol Med. 2009;15:553–61.
   PubMed Web of Science ®Google Scholar
• Patole PS, Gröne HJ, Segerer S, Ciubar R, Belemezova E, Henger A, et al. Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol. 2005;16:1326–38.
   PubMed Web of Science ®Google Scholar
• Tanaka H, Imaizumi T. Inflammatory chemokine expression via toll-like receptor 3 signaling in normal human mesangial cells. Clin Dev Immunol. 2013;2013:984708.
   PubMedGoogle Scholar
• Tanaka H, Imaizumi T. Mesangial viral and pseudoviral immunity: possible involvement in the pathogenesis of pediatric-onset active lupus nephritis. J Arthritis. 2015;4:183.
   Google Scholar
• Imaizumi T, Tanaka H, Matsumiya T, Yoshida H, Tanji K, Tsuruga K, et al. Retinoic acid-inducible gene-I is induced by double-stranded RNA and regulates the expression of CC chemokine ligand (CCL) 5 in human mesangial cells. Nephrol Dial Transplant. 2010;25:3534–9.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Aizawa T, Hayakari R, Xing F, Meng P, Tsuruga K, et al. Tumor necrosis factor-α synergistically enhances polyinosinic-polycytidylic acid-induced Toll-like receptor 3 signaling in cultured normal human mesangial cells: possible involvement in the pathogenesis of lupus nephritis. Clin Exp Nephrol. 2015;19:75–81.
   PubMed Web of Science ®Google Scholar
• Watanabe S, Imaizumi T, Tsuruga K, Aizawa T, Ito T, Matsumiya T, et al. Glomerular expression of myxovirus resistance protein 1 in human mesangial cells: possible activation of innate immunity in the pathogenesis of lupus nephritis. Nephrology (Carlton). 2013;18:833–7.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Aizawa T, Segawa C, Shimada M, Tsuruga K, Kawaguchi S, et al. Toll-like receptor 3 signaling contributes to the expression of a neutrophil chemoattractant, CXCL1, in human mesangial cells. Clin Exp Nephrol. 2015;19:761–70.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Shimada T, Matsumiya T, Yoshida H, Watanabe S, Tsuruga K, et al. Interferon-stimulated gene 15, a type I interferon-dependent transcript, is involved in a negative feedback loop in innate immune reactions in human mesangial cells. Nephron. 2016;132:144–52.
   PubMed Web of Science ®Google Scholar
• Imaizumi T, Aratani S, Nakajima T, Carlson M, Matsumiya T, Tanji K, et al. Retinoic acid-inducible gene-I (RIG-I) is induced in endothelial cells by LPS and regulates expression of COX-2. Biochem Biophys Res Commun. 2002;292:274–9.
   PubMed Web of Science ®Google Scholar
• Robson MG. Toll-like receptors and renal disease. Nephron Exp Nephrol. 2009;113:e1–7.
   PubMed Web of Science ®Google Scholar
• Conti F, Spinelli FR, Truglia S, Miranda F, Alessandri C, Ceccarelli F, et al. Kidney expression of toll-like receptors in lupus nephritis: quantification and clinicopathological correlations. Mediators Inflamm. 2016;2016:7697592.
   PubMed Web of Science ®Google Scholar
• Kuznik A, Bencina M, Svajger U, Jeras M, Rozman B, Jerala R. Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. J Immunol. 2011;186:4794–804.
   PubMed Web of Science ®Google Scholar
• Kawai T, Akira S. TLR signaling. Cell Death Differ. 2006;13:816–25.
   PubMed Web of Science ®Google Scholar
• Cui G, Ye X, Zuo T, Zhao H, Zhao Q, Chen W, Hua F. Chloroquine pretreatment inhibits toll-like receptor 3 signaling after stroke. Neurosci Lett. 2013;548:101–4.
   PubMed Web of Science ®Google Scholar